We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

0 hedge funds and large institutions have $0 invested in Nightstar Therapeutics plc American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 530 (-53)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

100% less capital invested

Capital invested by funds: $279M → $0 (-$279M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 53

Holders
Holders Change
-53
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
53
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
-$2K -100 Closed
PHK
52
Point72 Hong Kong
Hong Kong
-$2K -83 Closed
APA
53
American Portfolios Advisors
New York
-$431 -17 Closed

NITE Hedge Fund Activity: Q2 2019 in Review

0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q2 2019, worth a combined $0 — down 100% from $279M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NITE and 0 opened new positions — a net loss of 53 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TFG Asset Management, exiting entirely with an estimated $40.6M sold.

  • 0 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q2 2019, down from 53 in Q1 2019.
  • Funds reported $0 of Nightstar Therapeutics plc American Depositary Shares stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q2 2019 and 53 closed out, a net change of -53 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q2 2019 was TFG Asset Management, an estimated $40.6M sold.

Based on aggregated 13F filings for Q2 2019.